Equity Overview
Price & Market Data
Price: $2.35
Daily Change: $0.00 / 0.00%
Daily Range: $1.98 - $2.62
Market Cap: $27,520,400
Daily Volume: 90,330
Performance Metrics
1 Week: -2.08%
1 Month: -53.00%
3 Months: -74.32%
6 Months: -60.83%
1 Year: -70.63%
YTD: -74.32%
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
Nasus Pharma Ltd. operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.